Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Modeling neurodegeneration using induced pluripotent stem cells (iPSCs) Lauren Watson Division of Human Genetics Institute of Infectious Disease and Molecular Medicine Faculty of Health Sciences University of Cape Town Networking the Brain · UCT Cortex Club Inaugural Symposium · November 2014 Modeling neurodegeneration using induced pluripotent stem cells (iPSCs) • Research focus: Molecular basis of inherited conditions • Spinocerebellar Ataxia type 7 = Late-onset neurodegenerative disease • Major clinical manifestations: gait ataxia, macular atrophy • Caused by polyQ expansion in Ataxin-7 → toxic gain of function • Pathological hallmark = protein aggregates • Ataxin-7 forms part of TFTC/STAGA transcription coactivator complexes • Transcriptional dysregulation = early marker of disease • Problem: Lack of disease-relevant cell models 2 | Lauren Watson| Division of Human Genetics| Modeling neurodegeneration using iPSCs| 7 November 2014 Generation of iPSC-based neuronal models Robinton and Daley 2012 3 | Lauren Watson| Division of Human Genetics| Modeling neurodegeneration using iPSCs| 7 November 2014 Significance and impact • Greater understanding of pathogenesis of neurodegeneration, particularly regarding transcriptional dysregulation and cell stress response • Generation of cellular model of in vitro aging • Identification of disease phenotype which can be used to screen potential therapies • Use as a “pre- pre-clinical” screening tool, particularly in SA 4 | Lauren Watson| Division of Human Genetics| Modeling neurodegeneration using iPSCs| 7 November 2014 Techniques and Expertise • • • • • • • • • Anything to do with DNA! Sequencing and genotyping Immunocytochemistry qPCR Cell culture iPSC reprogramming iPSC characterisation Neuronal differentiation CRISPR/Cas9-mediated gene editing 5 | Lauren Watson| Division of Human Genetics| Modeling neurodegeneration using iPSCs| 7 November 2014 Why Neuroscience? • “By accident” • Functional analysis of gene mutations • Study inherited neurodegenerative disease in tissue of interest 6 | Lauren Watson| Division of Human Genetics| Modeling neurodegeneration using iPSCs| 7 November 2014 Career path • BSc PhD at UCT • Commonwealth Split-site Scholarship (Oxford) • Future: Postdoctoral fellowship at University of Oxford (2015) • Apply for everything! • Collaborate, network (conferences), learn (research visits), find a mentor • Work with a legacy in mind 7 | Lauren Watson| Division of Human Genetics| Modeling neurodegeneration using iPSCs| 7 November 2014 The future of Neuroscience at UCT • Main focus of our group: disease modeling using iPSCs • UCT Stem Cell Research Initiative • Scope to expand to other inherited conditions using our platform • We provide the cells, you provide the neuroscience applications! stemcells.uct.ac.za 8 | Lauren Watson| Division of Human Genetics| Modeling neurodegeneration using iPSCs| 7 November 2014 Acknowledgements University of Oxford Prof Matthew Wood Dr Sally Cowley Ms Jane Vowles Dr Helen Curtis Dr Miguel Varela Dr Liz Hartfield Wood Lab James Martin Stem Cell Unit University of Cape Town Prof Jacquie Greenberg Prof Sue Kidson Dr Robea Ballo Dr Danielle Smith Dr Joseph Raimondo Mr Richard Burman Ms Fiona Baine Hum Gen Lab UCT Stem Cell Research Initiative The Scripps Research Institute (USA) Assoc Prof Marco Weinberg Morris Lab Dr Mahito Nakanishi (National Institute of Advanced Industrial Science and Technology, Japan) Dr Janine Scholefield (CSIR) Funding Harry Crossley Foundation, NRF, MRC, Commonwealth Scholarships Commission, Ataxia UK, John Fell OUP Fund, UCT, National Ataxia Foundation, Keystone Symposia 9 | Lauren Watson| Division of Human Genetics| Modeling neurodegeneration using iPSCs| 7 November 2014